ArticleBMJ public health2026
Spatiotemporal distribution and clinical manifestations of moyamoya disease in Jiangxi Province, China: a retrospective hospital-based study.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Moyamoya disease (MMD) has been reported to be continuously increasing in China, with Jiangxi Province having the highest incidence nationwide. However, limited by data sources, national survey results have difficulty accurately reflecting the true incidence of MMD, indicating that detailed epidemiological data for this highest incidence province remain unavailable. Methods: We extracted medical records of MMD patients from 210 secondary and tertiary hospitals in Jiangxi Province from 2015 to July 2022. Spatiotemporal analysis was adopted to explore the spatial and temporal patterns and hospital burden of MMD in different counties and municipalities of Jiangxi Province. Results: A total of 18 693 hospitalisation records were included in this study, of which 11 140 were new-onset patients. The average annual incidence during 2015-2022 was 3.36 per 100 000 residents, with an average annual prevalence of 5.65 per 100 000 residents. The incidence exhibited a clustered regional distribution pattern ( Conclusions: This study is the first to comprehensively characterise the epidemiological characteristics and hospital burden of MMD in the highest incidence province of China. Our findings contribute to the development of effective public health policies, may provide novel insights into the aetiology of MMD and reduce the burden of MMD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.